212 related articles for article (PubMed ID: 2344859)
1. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.
Jansen JB; Jebbink MC; Douglas BR; Lamers CB
Eur J Clin Pharmacol; 1990; 38(4):367-70. PubMed ID: 2344859
[TBL] [Abstract][Full Text] [Related]
2. Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man.
Jebbink MC; Jansen JB; Mooy DM; Rovati LC; Lamers CB
Regul Pept; 1991 Feb; 32(3):361-8. PubMed ID: 1714084
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
[TBL] [Abstract][Full Text] [Related]
4. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
Gabryelewicz A; Kulesza E; Konturek SJ
Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.
Jebbink MC; Jansen JB; Masclee AA; Lamers CB
Br J Clin Pharmacol; 1990 Jun; 29(6):770-3. PubMed ID: 2378793
[TBL] [Abstract][Full Text] [Related]
6. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
[TBL] [Abstract][Full Text] [Related]
8. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
[TBL] [Abstract][Full Text] [Related]
9. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
[TBL] [Abstract][Full Text] [Related]
10. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.
de Jong AJ; Singer MV; Jansen JB; Niebel W; Rovati LC; Lamers CB
Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545
[TBL] [Abstract][Full Text] [Related]
11. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
12. Effect of loxiglumide on basal and gastrin- and bombesin-stimulated gastric acid and serum gastrin levels.
Jebbink MC; Lamers CB; Mooy DM; Rovati LC; Jansen JB
Gastroenterology; 1992 Oct; 103(4):1215-20. PubMed ID: 1397878
[TBL] [Abstract][Full Text] [Related]
13. Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism.
Lieverse RJ; Jansen JB; van de Zwan A; Samson L; Masclee AA; Rovati LC; Lamers CB
J Clin Endocrinol Metab; 1993 Jun; 76(6):1495-8. PubMed ID: 8501156
[TBL] [Abstract][Full Text] [Related]
14. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
[TBL] [Abstract][Full Text] [Related]
15. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W
Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406
[TBL] [Abstract][Full Text] [Related]
16. Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs.
Jansen JB; de Jong AJ; Singer MV; Niebel W; Rovati LC; Lamers CB
Dig Dis Sci; 1990 Sep; 35(9):1073-7. PubMed ID: 2390922
[TBL] [Abstract][Full Text] [Related]
17. Effect of duodenal juice on bombesin-stimulated cholecystokinin release during loxiglumide administration in man.
Jebbink MC; Jansen JB; van der Kleij FG; Mooy DM; Rovati LC; Lamers CB
Eur J Clin Invest; 1993 Sep; 23(9):529-33. PubMed ID: 8243522
[TBL] [Abstract][Full Text] [Related]
18. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
Konturek JW; Konturek SJ; Kurek A; Bogdal J; Oleksy J; Rovati L
Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511
[TBL] [Abstract][Full Text] [Related]
19. Bombesin reduces food intake after a preload in man by a cholecystokinin-independent mechanism.
Lieverse RJ; Jansen JB; Masclee AA; Lamers CB
Clin Sci (Lond); 1993 Sep; 85(3):277-80. PubMed ID: 8403798
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients.
Konturek JW; Konturek SJ; Domschke W
Scand J Gastroenterol; 1995 Aug; 30(8):738-44. PubMed ID: 7481540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
